Navigate physician non-competes, MSO structures, and cosmetic revenue valuations with a broker who specializes in healthcare and dermatology M&A.
Find Dermatology Practice Deals Without a BrokerDermatology practices are among the most sought-after acquisition targets in healthcare M&A, combining recurring medical revenue with high-margin cosmetic services like Botox and laser treatments. Independent practices generating $1M–$5M in revenue attract PE-backed roll-ups and physician entrepreneurs alike. A specialized broker ensures your deal accounts for payer mix complexity, corporate practice of medicine laws, and physician retention—the factors that make or break dermatology transactions.
Brokers focused exclusively on medical and dental practices, with direct experience in dermatology transactions, EMR transitions, payer contract reviews, and MSO deal structuring.
Best for: Sellers or buyers navigating physician employment agreements, malpractice history, and state CPOM compliance for the first time.
Investment banking-style advisors handling $2M–$10M enterprise value deals, running structured processes with multiple qualified buyers including PE-backed dermatology platforms.
Best for: Multi-physician practices or those with significant cosmetic revenue seeking competitive bidding from roll-up platforms and institutional buyers.
Advisors embedded within or closely aligned to PE-backed dermatology management companies, facilitating add-on acquisitions into existing regional or national platforms.
Best for: Practice owners open to partial exits, equity rollovers, and earnout structures tied to post-close EBITDA performance within a larger group.
Skip the broker — find deals direct
DealFlow OS surfaces off-market Dermatology Practice targets with seller signals and outreach angles. No commission.
How many dermatology or medical specialty practices have you closed in the last three years, and what were the typical deal structures used?
Dermatology deals often require MSO structures or equity rollovers. A broker without direct experience may misstructure the deal or undervalue cosmetic revenue streams.
How do you separate and value medical versus cosmetic revenue when determining our practice's EBITDA and asking price?
Cosmetic cash-pay revenue commands different margins and buyer interest than insurance-reimbursed medical dermatology. Misclassification can significantly distort your valuation.
What is your process for managing physician non-compete and retention risk disclosures during the sale process?
Buyer concern over key-person dependency is the top deal-killer in dermatology. A skilled broker manages this narrative proactively to protect valuation and deal momentum.
Do you have active relationships with PE-backed dermatology roll-up platforms and SBA lenders who finance physician-led acquisitions?
Access to the right buyer pool—both institutional and individual—directly impacts your final multiple, which ranges from 4x to 7x EBITDA in this specialty.
Dermatology practices typically sell for 4x–7x EBITDA. Practices with strong cosmetic revenue, multiple providers, and diversified payer mix command the higher end of that range.
Direct ownership is restricted by corporate practice of medicine laws in many states. Most deals use an MSO structure where a non-physician entity manages operations while a physician entity holds the clinical license.
Expect 12–24 months from preparation to close. Practices with clean financials, current payer contracts, and documented cosmetic revenue move faster through buyer due diligence.
Most buyers require a 12–24 month transition or employment period, often tied to an earnout. PE platforms frequently offer equity rollover as part of partial-exit deal structures.
More Dermatology Practice Guides
Find Brokers in Other Industries
DealFlow OS surfaces off-market targets, scores seller motivation, and writes your outreach. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers